0001104659-23-027555.txt : 20230301 0001104659-23-027555.hdr.sgml : 20230301 20230301214627 ACCESSION NUMBER: 0001104659-23-027555 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221004 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: De Paolantonio Ernest Robert CENTRAL INDEX KEY: 0001588538 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41063 FILM NUMBER: 23696219 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Journey Medical Corp CENTRAL INDEX KEY: 0001867066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471879539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 BUSINESS PHONE: 480-434-6670 MAIL ADDRESS: STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 4/A 1 tm237728-1_4aseq1.xml OWNERSHIP DOCUMENT X0306 4/A 2022-10-04 2022-10-06 1 0001867066 Journey Medical Corp DERM 0001588538 De Paolantonio Ernest Robert C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DEVENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 0 1 0 0 See Remarks Common Stock, par value $0.0001 per share 2022-10-04 4 S 0 10093 2.41 D 259907 D In connection with the vesting of 40,000 shares on October 1, 2022, a total of 10,093 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Due to a clerical error, the original Form 4 filed on October 6, 2022 reflected an acquisition of 10,029 shares in lieu of a disposition of 10,029 shares. The amount of securities beneficially owned following the reported transaction reported in the previously filed Form 4 is correct. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 4, 2022, was $2.38 to $2.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price. Includes restricted stock units, which vest over various time periods. As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issuer. In a Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 20, 2023, the Issuer announced that the Reporting Person provided notice of his resignation to the Issuer on January 16, 2023 and, as such, is no longer a Section 16 filer as of the date of this amendment. /s/ Ramsey Alloush, attorney-in-fact 2023-03-01